Patent details

Basic Information

Publication number:

EP2044121

PCT Application Number:

PCT/EP/2007/006123

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP078014222

PCT Publication Number:

WO/2008/006554

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GLYCO-ENGINEERED ANTIBODIES

French Title of Invention:

ANTICORPS GLYCO-MODIFIES

German Title of Invention:

GLYCO-MANIPULIERTE ANTIKÖRPER

SPC Number:

Dates

Filing date:

11/07/2007

Grant date:

21/08/2013

EP Publication Date:

21/08/2013

PCT Publication Date:

17/01/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2009

EP B1 Publication Date:

21/08/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/07/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/07/2007

 

 

Name:

Greenovation Biotech GmbH

Address:

Bötzinger Strasse 29b, 79111 Freiburg i.Br, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

28/08/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SCHUSTER Manfred

Address:

Austria (AT)

2

Name:

NECHANSKY Andreas

Address:

Austria (AT)

3

Name:

KIRCHEIS Ralf

Address:

Austria (AT)

4

Name:

GORR Gilbert

Address:

Germany (DE)

5

Name:

JOST Wolfgang

Address:

Germany (DE)

Priority

Priority Number:

06450095

Priority Date:

11/07/2006

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07K 16/28;

Annual Fees

Annual Fee Due Date:

31/07/2026

Annual Fee Number:

20

Annual Fee Amount:

300 Euro

Expected Payer:

Last Annual Fee Payment Date:

22/07/2025

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

PAVIS GMBH

Filing date	Document type	Number of pages